Quest Diagnostics Women’s Health

Laboratory services are one of the many essential pillars supporting the preservation of maternal and fetal health. That’s why Dr. Pat Alagia and Meredith Masiello sat down to discuss the unique services offered by Quest Diagnostics that help clinicians and patients throughout the pregnancy journey. Listen to their full discussion below:

“In my role as a Genomic Science Specialist (GSS) at Quest Diagnostics, my team and I speak to patients every day about their results. The most important part of our job is to listen carefully and empathetically to questions and concerns.” Supporting clinicians in providing patients the proper support when seeking prenatal genetic screening is what our Genomic Client Services team does best. Read more about the perspectives of Julia Wilkinson, Genomic Science Specialist at Quest, and learn more about our supporting solutions. www.questprenatal.com

Designed with ACOG and ACMG recommendations in mind, QHerit® and QNatal® offer OBGYNs high-quality prenatal genetic screenings and relevant answers to help guide their patients’ pregnancy journeys. Learn more about our unique offerings here:

As the prenatal genetics field rapidly evolves, support through every step of the pregnancy journey is more important than ever. Quest’s QHerit® carrier screening and QNatal® Advanced noninvasive prenatal screening make it easy for your patients to get the testing they need, when they need it. Learn more about the benefits of our support services and comprehensive portfolio here:

Recently, the American College of Obstetricians and Gynecologists (ACOG) issued updated recommendations for syphilis screening, stating that all pregnant individuals should be “screened serologically for syphilis at the first prenatal care visit, followed by universal rescreening during the third trimester and at birth, rather than use a risk-based approach to testing.” This change marks an important step in strengthening the public health response towards eradicating syphilis. Make it easier for patients to get the testing they need with our comprehensive STI portfolio, inclusive of a suite of tests and panels to help screen for and diagnose syphilis, as well as monitor your patient’s response to treatment: #STIAwareness #WomensHealthMonth

With the prevalence of syphilis increasing rapidly within the US, especially for women, it’s valuable to understand the history and current public health efforts surrounding it.¹ Read more in our latest blog about this complex condition and what Quest Diagnostics Women’s Health offers in the face of it. #STIAwareness Reference: 1. NPR. https://lnkd.in/eepXYhqS

Positive cases of chlamydia (CT) and gonorrhea (NG) continue to rise.¹ The Centers for Disease Control and Prevention STI Treatment Guidelines recommend screening all female patients ages 15-24 for CT/NG regardless of their reported sexual activity, to help close gaps in testing.²‵³ Explore all of our resources that can help you seamlessly implement universal screening into your practice: #STIAwarenessWeek References: 1. CDC. Sexually Transmitted Infections Surveillance, 2022. https://lnkd.in/gA5aVSKy 2. CDC. Chlamydial Infections. https://lnkd.in/enWPTRFv 3. CDC. Gonococcal Infections Among Adolescents and Adults. https://lnkd.in/e_GQiJnA

During this year’s #LabWeek, we celebrate the countless lab and pathology professionals nationwide who continuously strive to enhance the health of our communities. You are at the core of healthcare and patient advocacy, making the lab the beating heart of it all.

Nearly 1 in 2 sexually transmitted infections occur in people ages 15-24, according to the CDC.¹ This #STIAwarenessWeek, protect your patients’ health by making universal screening with opt-out for chlamydia (CT) and gonorrhea (NG) the standard of care in your practice. Learn more about how your patients can benefit from our comprehensive STI testing portfolio: Reference: 1. CDC. https://lnkd.in/eXMU3Nuw

Learn more below about ReproSource and what they can do for your patients and their futures: #EndometriosisAwarenessMonth